prostate cancer resistant to conventional treatment could be all but wiped out by a therapy that boosts the immune system , claim researchers
the us scientists used low doses of the drug oxaliplatin , which has a unique ability to activate cancer - killing immune cells in small tumours but works less well in large , aggressive tumours
each year in the uk around 41,000 men are diagnosed with prostate cancer and 11,000 die from the disease the problem is partly caused by immune system â b - cells â that put a brake on the body âs defences in prostate and other cancers